Business
Eli Lilly CEO Voices Opposition to Legislative Mandates on Drug Pricing Models.
April 1, 2026 at 5:36 PM
Eli Lilly CEO David Ricks has publicly opposed White House efforts to codify 'most favored nation' drug pricing agreements into federal law, signaling a shift in the pharmaceutical industry's relationship with the administration's pricing strategies.

